COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02696044
Recruitment Status : Recruiting
First Posted : March 2, 2016
Last Update Posted : July 17, 2020
Ultragenyx Pharmaceutical Inc
Rett Syndrome Research Trust
Information provided by (Responsible Party):
Daniel C. Tarquinio, Center for Rare Neurological Diseases, Norcross, GA

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2022